RARA CRAFT DATABASE for FDA Medical Devices
510(k)K220075

FDA DEVICE FACTS

Spartan Center Wire

Spartan Micro, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEApril 19, 2022PRODUCT CODEDQX

Indications for use

Spartan Center Wire™ Predicate K022357 Transend™ 300 Floppy Guidewire, Model 46-815 The Spartan Center Wire™ is indicated for general intravascular use in the peripheral vasculature. It can be deployed into the vessel to facilitate the selective placement of diagnostic or therapeutic catheters.

The device is not intended for use in the coronary or neuro vasculature.

The Transend™ 300 ES Guidewire and Transend™ 300 Floppy Guidewire are intended for general intravascular use, including the neuro and peripheral vasculature. The guidewires can be torqued to facilitate the selective placement of diagnostic or therapeutic catheters. These devices are not intended for use in coronary arteries. A torque device (pin vise) is included to facilitate directional manipulation of the guidewires. Spartan Center Wire™ Premarket Notification 510(k) The Spartan Center Wire™ is indicated for use in the peripheral vasculature while the Transend™ 300 Floppy Guidewire is for use in the peripheral and neuro vasculature.

No torque device is needed or supplied with the Spartan Center Wire™.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 22, 2026